No Detail Found!

Clinical Utility of Serum Dehydroepiandrosterone Sulfate (DHEA-S) and Serum Anti-Mullerian Hormone (AMH) Levels in Infertile Females

Author(s)
Rimsha Sehar Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Muhammad Younas Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Muhammad Qaiser Alam Khan Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Zujaja Hina Haroon Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Muhammad Anwar Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Muhammad Usman Munir Department of Chemical Pathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Abstract
Objective: To determine the correlation of serum dehydroepiandrosterone sulphate and anti-mullerian hormone levels with infertility in females. Study Design: Cross-sectional study. Place and Duration of the Study: Department of Chemical Pathology, the Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from July 2022 to August 2023. Methodology: About 110 infertile females with infertility were enrolled in this study. Serum thyroid-stimulating hormone, luteinising hormone, testosterone, follicle-stimulating hormone (FSH), estradiol, serum Anti-Mullerian Hormone (AMH), and Dehydroepiandrosterone Sulphate (DHEA-S) were measured at 3rd menstruation day. Females with primary ovarian insu ciency, using androgen supplementation, and on hormonal therapy were excluded. Results: Among the participants, 63.6% had primary infertility and 36.4% had secondary infertility. Both primary and secondary infertility had a positive correlation with serum AMH and DHEA-S levels (r = 0.685; p <0.001) and (r = 0.807; p <0.001), respectively. After ultrasound, 54 (49.1%) females were normal, 12 (10.9%) had PCOS, 12 (10.9%) had broids, 8 (7.3%) had fallopian tube defects, 10 (9.1%) had endometriosis, and 14 (12.7%) had low antral follicular count. The correlation between serum AMH and DHEA-S with di erent subgroups is as follows: Normal females (r = 0.731; p <0.001), PCOs (r = -0.232; p = 0.468), broids (r = 0.941, p <0.001), fallopian tube defects (r =-0.800; p = 0.017), endometriosis (r = -0.684, p = 0.013), and low antral follicular count (r = 0.643, p = 0.0130). Conclusion: This study demonstrated a positive correlation between serum AMH and DHEA-S levels in infertile females.
Publication Details
Page(s) 157-161
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Ovarian reserve, Infertile women, Anti-mullerian hormone, Dehydroepiandrosterone sulphate
References
Borght MV,Wyns C.,Fertility C. .2018 .. Clin Biochem, 03 : 2-10.
Habiba M,Heyn R,Bianchi P,Brosens I,Benagiano G. .2021 .The development of the human uterus: Morphogenesis to menarche. Hum Reprod Update, 10(1) : 1-26.
Kubiak JZ,Kloc M,Piprek R .2020 .History of the research on sex determination. Biomed J Sci Technol Res, 25(3) : .
Sivanandy MS,Ha SK .2023 .The role of serum anti-mullerian hormone measurement in the diagnosis of polycystic ovary syndrome. Diagnostics, 10(5) : 907.
Salemi F,Jambarsang S,Kheirkhah A,Abargouei AS,Ahmadnia Z,Lot M .2024 .The best ovarian reserve marker to predict ovarian response following controlled ovarian hyperstimulation: A systematic review and meta-analysis. Syst Rev, 10(1) : 1-21.
Russell N,Gilmore A,Roudebush WE .2022 .Clinical utilities of anti-mullerian hormone. J Clin Med, 10(23) : 7209.
Schi L,Barnard L,Baranowski ES,Gilligan LC,Taylor AE,Arlt W .2019 .Human steroid biosynthesis, metabolism and excretion are di erentially re ected by serum and urine steroid metabolomes: A comprehensive review. J Steroid Biochem Mol Biol, 105439 : 105439.
Lin LT,Tsui KH .2021 .The relationships between serum DHEA-S and AMH levels in infertile women: A retrospective crosssectional study. J Clin Med, 10(6) : 1211.
Shaheen R,Subhan F,Sultan S,Subhan K .2010 .Prevalence of infertility in a cross section of Pakistani population. Pak J Zool, 42(4) : 389-93.
Grisendi V,Mastellari E,La Marca A .2019 .Ovarian reserve markers to identify poor responders in the context of poseidon classi cation. Front Endocrinol, 00281 : 281.
Brouwer J,Laven JS,Hazes JM,Schipper I,Dolhain RJ .2013 .Levels of serum anti mullerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res, 10(9) : 1534-8.
Al-hadrawi KK .2023 .The role of some of the level Antioxidant enzymes and Obesity in development infertility women s infertility in Najaf Province Patients, IRAQB. IO Web of Conferences, 10 : 05050.
Li Y,Ren J,Li N,Liu J,Tan SC,Low TY .2020 .A dose-response and meta-analysis of dehydroepiandrosterone (DHEA) supplementation on testosterone levels: Perinatal prediction of randomized clinical trials. Exp Gerontol, 111110 : 111110.
Lin LT,Li CJ,Tsui KH .2021 .Serum testosterone levels are positively associated with serum anti-mullerian hormone levels in infertile women. Sci Rep, 10(1) : 6336.
Dewailly D,Robin G,Peigne M,Decanter C,Pigny P,Jonard SC .2016 .Interactions between androgens, FSH, anti-mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update, 10(6) : 709-24.
Hu Q,Hong L,Nie M,Wang Q,Fang Y,Dai Y .2017 .The e ect of dehydroepiandrosterone supplementation ovarian response is associated with androgen receptor in diminished ovarian reserve women. J Ovarian Res, 10(1) : 1-0.
Xie M,Zhong Y,Xue Q,Wu M,Deng X,Santos HO .2020 .Impact of dehydroepianrosterone (DHEA) supplementation on serum levels of insulin-like growth factor 1 (IGF-1): A dose-response meta-analysis of randomized controlled trials. Exp Gerontol, 110949 : 110949.
Gleicher N,Weghofer A,Barad DH .2010 .Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reprod Biomed Online, 04(3) : 360-5.
Yilmaz N,Uygur D,Inal H,Gorkem U,Cicek N,Mollamahmutoglu L .2013 .Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: Serum AMH, inhibin B and antral follicle count. Eur J Obstet Gynecol Reprod Biol, 04(2) : 257-60.
Zhang M,Niu W,Wang Y,Xu J,Bao X,Wang L .2016 .Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: A systematic review and meta-analysis. J Assist Reprod Genet, 10 : 981-91.
Yeung TW,Chai J,Li RH,Lee VC,Ho PC,Ng EH .2014 .A randomized, controlled, pilot trial on the e ect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders. Fertil Steril, 03(1) : 108-15.
0

Citations

0

Downloads

65

Views